PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12100748-7	2002	CCK-B receptor antagonist L-365,260 (30 nmol/L) reversed the antagonism of CCK-8 to the effect of morphine.	Sincalide	75-80	cholecystokinin B receptor	Rattus norvegicus	0-14	
31308730-7	2019	RVM microinjection of the CCK2 receptor agonist CCK-8 and intrathecal injection of the 5-HT2B receptor agonist BW723C86 both produced hyperalgesia in female rats after plantar incision, whereas the CCK2 receptor antagonist YM022, the 5-HT2B receptor antagonist RS127445, and the PKCgamma inhibitor C37H65N9O13 decreased the rats" sensitivity to the same stimulus.	Sincalide	48-53	cholecystokinin B receptor	Rattus norvegicus	26-39	
12100748-9	2002	The antagonistic effect of CCK-8 on morphine was mainly mediated by CCK-B receptor.	Sincalide	27-32	cholecystokinin B receptor	Rattus norvegicus	68-82	
9174069-5	1997	CCK-8-induced suppression was completely abolished by (+)L-365,260, a selective CCK(B) receptor antagonist, but not by (-)L-364,718, a selective CCK(A) receptor antagonist.	Sincalide	0-5	cholecystokinin B receptor	Rattus norvegicus	80-95	
11324560-3	1998	The CCK-8 effect, again, could be suppressed by CCK-A receptor antagonist devazepide (10 nmol/L), but partially by CCK-B receptor antagonist L-365, 260 at 10 nmol/L or completely at concentration of 30 nmol/L.	Sincalide	4-9	cholecystokinin B receptor	Rattus norvegicus	115-129	
8531095-5	1995	The effect of CCK-8 can in turn be abolished by the CCK-B receptor antagonist L365,260.	Sincalide	14-19	cholecystokinin B receptor	Rattus norvegicus	52-66